Author:
Shah Chirag,Singh Ramandeep,Chauhan Rohan,Saxena Ashish,Shah Anup,Mondal Laxshmi,Bakhle Dhananjay,Shah Arpit,Deoghare Shashank,Krishnan Neelakant,Godse Neelima
Reference22 articles.
1. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The right to sight: An analysis for the Global Burden of Disease Study. Lancet Glob Health 2021;9:e144-e160. Erratum in: Lancet Glob Health 2021;9:e408.
2. Blindness and vision impairment. Available from: https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment. [Last accessed on 2021 Jul 05]
3. Tan CS, Sadda SR. Neovascular (Wet) age-related macular degeneration. In: Chhablani J, Ruiz-Medrano J, editors. Choroidal Disorders. Academic Press; 2017. p. 89-116.
4. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006
5. Ranibizumab (Lucentis) versus bevacizumab (Avastin);Raftery;Br J Opthalmol,2007
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献